The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

12 Sep 2023 10:30

RNS Number : 1745M
Mobeus Income & Growth 2 VCT PLC
12 September 2023
 

MOBEUS INCOME & GROWTH 2 VCT PLC

("the Company")

LEI: 213800LY62XLI1B4VX35

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2023

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

At 30 June 2023

(unaudited)

At 31 March 2023

(audited)

Net assets attributable to shareholders

£71,597,619

£70,426,557

Shares in issue

98,437,045

98,437,045

Net asset value (NAV) per share

72.73p

71.54p

Cumulative dividends paid

147.00p

147.00p

Cumulative Total return (net asset value basis) per share since inception

219.73p

218.54p

 

Net asset value (NAV) per share has increased by 1.19 pence, or 1.7% over the period. This increase is primarily due to a rise in unrealised valuations over the first three months of the financial year. No dividends have been paid in the period.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investments

On 3 May 2023, a new equity investment of £0.39 million was made into Dayrize B.V., a provider of a rapid sustainability impact assessment tool.

 

Share Buybacks

No shares were bought back in the quarter.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

New investments after the period end

On 26 July 2023, a new equity investment of £0.32 million was made into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, a new equity investment of £0.32 million was made into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Follow-on investments after the period end

On 4 July 2023, a follow on equity investment of £0.30 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.11 million was made into Orri, an intensive day care provider for adults with eating disorders.

 

Share Buybacks after the period end

On 18 July 2023, the Company purchased 336,876 of its own ordinary shares at a price of 67.96 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary

020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKLLBFXKLLBBX
Date   Source Headline
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
10th Sep 20195:00 pmRNSNotice of GM
8th Aug 201910:59 amRNSInterim Management Statement to 30 June 2019
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription
2nd Jul 20199:16 amRNSRealisation of investment
1st Jul 201911:43 amRNSTransaction in Own Shares
25th Jun 20191:04 pmRNSAnnual Financial Report
24th Jun 20198:52 amRNSTransaction in Own Shares
19th Jun 20191:49 pmRNSAnnual Results for the year ended 31 March 2019
4th Mar 20199:18 amRNSTransaction in Own Shares
13th Feb 20191:55 pmRNSInterim Management Statement - 3rd Quarter
17th Dec 20189:43 amRNSTransaction in Own Shares
21st Nov 201810:27 amRNSHalf-year Report
12th Sep 20182:18 pmRNSAGM Statement
11th Sep 20183:18 pmRNSInterim Management Statement to 30 June 2018
14th Aug 20183:58 pmRNSNet Asset Value(s)
26th Jun 20182:53 pmRNSNSM Filing
22nd Jun 20183:04 pmRNSAnnual Financial Report
14th Jun 20189:00 amRNSDirectorate Change
27th Mar 20184:53 pmRNSTransaction in Own Shares
13th Mar 20184:32 pmRNSIssue of Equity
9th Feb 201810:35 amRNSInterim Management Statement
25th Jan 20189:34 amRNSIssue of Equity
5th Jan 201812:37 pmRNSRealisation of Investment in Gro-Group
5th Jan 201811:22 amRNSTotal Voting Rights
21st Dec 20179:20 amRNSTransaction in Own Shares
20th Dec 20171:54 pmRNSPublication of Suppl.Prospcts
12th Dec 20172:21 pmRNSHalf-year Report
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:29 amRNSIssue of Equity
21st Nov 201710:01 amRNSIssue of Equity
10th Nov 201710:25 amRNSIssue of Equity
1st Nov 201712:43 pmRNSIncrease in Offer size. Expiry of early incentive.
20th Oct 20172:22 pmRNSIssue of Equity
13th Oct 201711:23 amRNSOver-Allotment Facility
2nd Oct 20175:20 pmRNSTransaction in Own Shares
2nd Oct 20175:17 pmRNSTransaction in Own Shares
29th Sep 201710:21 amRNSDirector/PDMR Shareholding _ Replacement
29th Sep 201710:20 amRNSDirector/PDMR Shareholding - Replacement
29th Sep 20179:15 amRNSDirector/PDMR Shareholding
29th Sep 20179:10 amRNSDirector/PDMR Shareholding
29th Sep 20179:06 amRNSIssue of Equity
15th Sep 201710:19 amRNSInterim Management Statement - Replacement
15th Sep 20177:05 amRNSInterim Management Statement
14th Sep 20172:34 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.